Navigation Links
Too Much Or Little Sleep Increases Risk Of Diabetes

According to a study by the New England Research Institutes in collaboration with Yale School of Medicine researchers men who sleep too much or too little// are at a greater risk of developing type II diabetes. The data originally published in March is based on studies done on over 1709 men, in the age groups of 40–70, the men were studied on over a period of 15 yrs.

According to the lead researcher Dr.H.Klar Yaggi, M.D., professor in Yale's Department of Internal Medicine, pulmonary section. It was found that men with 6-8 hrs sleep were most healthy. In Comparison men who stated that they slept between 5-6 hrs a night were twice as likely to develop diabetes, while those who slept for more than 8 hrs were three times at risk. The risks were the same after they had separated risk groups like, hypertension, smoking, etc.

With these studies he felt the researchers know beginning to understand the hormonal and metabolic implication sleep. As of now and the research he felt that men sleeping too little, are having marked alterations in the metabolic and hormonal functions including decreased carbohydrate tolerance, insulin resistance, and lower levels of the hormone leading to obesity. They are still studying the men with longer sleep durations. The studies are also trying to determine if disorders of sleep can also cause or worsen the metabolic syndrome.


'"/>




Page: 1

Related medicine news :

1. Little sleep as bad as no sleep
2. Aspirin Induced Asthma , A Little-Known Inducer
3. A Little Weight Loss Found To Make A Significant Difference In Men
4. Little Known DNA Repair Enzyme May Be A Tumor Suppressor Gene
5. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
6. Trendsetters: Little girls fast track into ladies even before they know it
7. The Little Known Facts of Junk DNA
8. Diabetes Risk Pronounced With Too Much or Too Little Sleep
9. Reverse Heart Transplant Surgery On A Little Girl Makes History
10. Most People With Arthritis Do Little Or No Exercise At All
11. Little Makoda-Poster Girl For Leukemia Awareness Campaign Losses Her Battle Of Life
Post Your Comments:
(Date:12/7/2009)... Results of two new studies support the use ... (AED) Vimpat® for patients requiring add-on therapy in ... not feasible. These data, which were presented ... the American Epilepsy Society in Boston, further clarify ... setting. ,, One study shows that patients can ...
(Date:12/7/2009)... -- Micromet, Inc. (Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune diseases, today ... data from its ongoing phase 1 clinical trial ... non-Hodgkin,s lymphoma (NHL) at the 51ST Annual Meeting ... New Orleans, Louisiana. Blinatumomab is a CD19-specific, T ...
(Date:12/7/2009)... couple years ago, lead paint in toys manufactured ... made in the USA. This fall, news of ... toys are suspect. Renowned parenting expert Dr. Jeffrey ... harmful to developing brains, retarding language development and ... sense of separation, which is the defining trait ...
(Date:12/7/2009)... Barduson was recently named executive chairman of the board of ... physicians in hospitals and practices nationwide. , ... ... Gene Barduson was recently named executive chairman of the ... company currently serving 13,000 physicians in hospitals and practices nationwide. ...
(Date:12/7/2009)... PALM BEACH, Fla., Dec. 7 The ... TransMedia Group to publicize the first major ... the Simply 66 Snap System, which is already ... TransMedia Group ( www.transmediagroup.com ) was selected as ... profile in print, broadcast, online and social networking ...
Breaking Medicine News(10 mins):Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 2Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 3Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 4Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 5Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:Gene Barduson Named Chairman of PerfectServe Board of Directors 2Health News:Cubicle Curtain Factory Retains TransMedia Group to Promote First Privacy Curtain to Reduce Hospital Maintenance Cost 2
... indoor plumbing to be the pinnacle of sanitary ... better solution for many parts of the developing ... Associate Professor David Watkins, Professor James Mihelcic and ... Futures Institute analyzed worldwide barriers to sanitation. Diseases ...
... the hormone could boost death risk, researchers say , , ... levels put men at high risk for cardiovascular disease, ... help better the odds, according to new studies. ... become more common with age, are linked to several ...
... in the strength of cannabis over the last decade is ... users are not borne out by a study of the ... Research Centre (NDARC) and the National Drug Research Institute (NDRI), ... this month,s issue of ADDICTION, are that increased potency has ...
... Health Care & Economic Security - Need,for Lawmakers to ... 17 150 years ago,this week, Abraham Lincoln delivered ... Springfield. AARP Illinois took the opportunity,to remind state and ... of division preventing progress on key issues remains the,same., ...
... creators of the leading exergaming ,Brand Xperience, ... the exergaming market in ... iTech Fitness Inc.,( http://www.iTechFitness.com ), creators of the ... signing of the 50th XRKade,location in North America with ...
... Associates, leading analysts will,explore the implications of high-speed ... homes as a kickoff to CONNECTIONS(TM): The,Digital Living ... Top Trends to Watch, Tuesday, June 24,will feature ... on trends in,broadband and access services, video delivery, ...
Other Medicine News:Health News:Studies Support Testosterone Supplements for Older Men 2Health News:Claims linking health problems and the strength of cannabis may be exaggerated 2Health News:150 Years Later 'House Divided' Speech Still Holds Strong Message 2Health News:XRKade Signs 50th Location in North America and Announces Expansion Plans 2Health News:Parks Associates Analysts Present Insights on Broadband, Digital Content, Advertising, Home Systems, and Digital Health at CONNECTIONS(TM) 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, announced today the presentation of new data from ... recombinant Protective Antigen (rPA) based anthrax vaccine is structurally ... up to and including 55 degrees C. The ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Web Based Psychotherapy Can Work 55000 1Web Based Psychotherapy Can Work 55000 2Web Based Psychotherapy Can Work 55000 3Learning how to cope with burn injuries 54996 1Learning how to cope with burn injuries 54996 2Learning how to cope with burn injuries 54996 3Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 1Missouri Botanical Garden hosts historic meeting to discuss endangered plants in the Caucasus region 9646 2
... ANTIPOLIS, France, Oct. 2 NicOx S.A.,(Eurolist: ... clinical and,preclinical results from its collaboration with ... of Dermatology, in Buenos Aires, Argentina.,These included ... prototype compound, showing,the potential for improved safety ...
... Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) today announced that ... overview of the Company,s cancer,pipeline at the upcoming William ... City. Dr. Henderson,s presentation will take place,on Wednesday, October ... will be webcast live and will be,accessible from the ...
Other Medicine Technology:NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 2NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology 3Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2